Board MeetingJul 9, 2026, 08:44 AM
Dare Bioscience to Present at Virtual Investor Closing Bell Event
AI Summary
Dare Bioscience, Inc. announced its participation in a Virtual Investor Closing Bell event on Tuesday, July 14, 2026, at 4:00 PM ET. President and CEO Sabrina Martucci Johnson will provide a corporate overview, highlighting the recent launch of FloraSync LF5™, the company's commercial strategy, pipeline advancements, and milestones for long-term growth. The event will also cover Dare's approach to capital allocation and include a live Q&A session.
Key Highlights
- Dare Bioscience to participate in Virtual Investor Closing Bell event on July 14, 2026.
- CEO Sabrina Martucci Johnson will provide a corporate overview.
- Discussion to highlight the recent launch of FloraSync LF5™.
- Company strategy for commercial business and women's health pipeline will be presented.
- Milestones for long-term growth and capital allocation approach will be covered.
- A live question and answer session will be included for audience participants.
Price Impact
More from DARE